Clinical implications of recurring mutations in myxoid liposarcoma (MLS) von Thirasastr, Prapassorn, Lin, Heather Y., Nassif, Elise F, Wang, Wei-Lien, Araujo, Dejka M., Benjamin, Robert S., Conley, Anthony Paul, Livingston, J Andrew Andrew, Ludwig, Joseph Aloysius, Patel, Shreyaskumar, Ratan, Ravin, Ravi, Vinod, Zarzour, Maria Alejandra, Zhou, Xiao, Somaiah, Neeta

Volltext

Phase I study of the mutant IDH1 inhibitor ivosidenib: Long-term safety and clinical activity in patients with conventional chondrosarcoma von Tap, William D., Cote, Gregory Michael, Burris, Howard A., Gore, Lia, Beeram, Muralidhar, Conley, Anthony Paul, Gianolio, Diego A., Qu, Zhe, Gliser, Camelia, Pandya, Shuchi Sumant, Trent, Jonathan C.

Volltext

Initial results from a first in human dose escalation trial of a novel immune stimulating oncolytic adenovirus, AdAPT-001 TGF-ß Trap von Conley, Anthony Paul, Roland, Christina Lynn, Gastman, Brian, Villaflor, Victoria Meucci, Larson, Christopher, Reid, Tony R., Caroen, Scott, Alizadeh, Babak, Oronsky, Bryan, Stirn, Meaghan, Williams, Jeannie, Burbano, Erica, Coyle, Angelique, Barve, Minal A., Wagle, Naveed, Abrouk, Nacer, Kesari, Santosh

Volltext

Outcomes in late-line systemic treatment in GISTs: Does sequence matter? von Thirasastr, Prapassorn, Joseph, Cissimol, Araujo, Dejka M., Benjamin, Robert S., Conley, Anthony Paul, Livingston, J Andrew Andrew, Ludwig, Joseph Aloysius, Patel, Shreyaskumar, Ratan, Ravin, Ravi, Vinod, Zarzour, Maria Alejandra, Zhou, Xiao, Somaiah, Neeta

Volltext

Clinical characteristics and outcomes of adult alveolar rhabdomyosarcoma (ARMS) patients on front-line therapies: An MD Anderson Cancer Center (MDACC) case series von Nakazawa, Michael, Livingston, J Andrew Andrew, Bishop, Andrew Justin, Zarzour, Maria Alejandra, Somaiah, Neeta, Ratan, Ravin, Gill, Jonathan Benjamin, Urquiola, Elizabeth, Posey, Kristi, Guadagnolo, Beverly Ashleigh, Gorlick, Richard Greg, Benjamin, Robert S., Patel, Shreyaskumar, Conley, Anthony Paul

Volltext

A randomized, placebo-controlled, phase 2 trial of INBRX-109 in unresectable or metastatic conventional chondrosarcoma von Chawla, Sant P., Wasp, Garrett Thomas, Shepard, Dale Randall, Blay, Jean-Yves, Jones, Robin Lewis, Stacchiotti, Silvia, Reichardt, Peter, Gelderblom, Hans, Martin-Broto, Javier, Eckelman, Brendan, Darling, Michelle, Andrianov, Vasily, Conley, Anthony Paul

Volltext

Safety and efficacy of percutaneous image‐guided ablation for soft tissue sarcoma metastases to the liver von Awad, Ahmed, Pal, Koustav, Yevich, Steven, Kuban, Joshua D., Tam, Alda, Odisio, Bruno C., Gupta, Sanjay, Habibollahi, Peiman, Bishop, Andrew J., Conley, Anthony Paul, Somaiah, Neeta, Araujo, Dejka M., Zarzour, Maria Alejandra, Ratan, Ravin, Roland, Christina L., Keung, Emily Z., Huang, Steven Y., Sheth, Rahul A.

Volltext

A phase 2 study of an anti–PD-L1 antibody (atezolizumab) in dedifferentiated chondrosarcoma von Salkeni, Mohamad Adham, Ko, Brian, Van Tine, Brian Andrew, Conley, Anthony Paul, Davis, Elizabeth J., Burgess, Melissa Amber, Close, Julia Lee, Foster, Jared C., O'Sullivan Coyne, Geraldine Helen, Moore, Nancy, Fino, Kristin K., Ferry-Galow, Katherine V., Rosenberger, Christina, Parchment, Ralph E., Sharon, Elad, Doroshow, James H., Chen, Alice P.

Volltext

ETCTN/NCI 10330: A phase 2 study of belinostat with SGI-110 (guadecitabine) or ASTX727 (decitabine/cedazuridine) for the treatment of unresectable and metastatic conventional chond... von Lacuna, Kristine Peregrino, Lee, Shing M, Ge, Liner, Druta, Mihaela, Conley, Anthony Paul, Keohan, Mary Louise, Agulnik, Mark, Burgess, Melissa Amber, Chalmers, Anna Weinberg, D'Amato, Gina Z., Powers, Benjamin, Seetharam, Mahesh, Siontis, Brittany L, Weiss, Mia C., Bose, Sminu (Sam), Sheikh, Tahir, Piekarz, Richard, Schwartz, Gary K., Ingham, Matthew

Volltext

Phase Ib study of selinexor and eribulin combination in advanced solid tumors and triple-negative breast cancer von Nelson, Blessie Elizabeth, Saleem, Sadia, Damodaran, Senthil, Somaiah, Neeta, Piha-Paul, Sarina Anne, Moore, Julia Ann, Yilmaz, Bulent, Karp, Daniel D., Dumbrava, Ecaterina Elena, Tsimberidou, Apostolia Maria, Hong, David S., Rodon Ahnert, Jordi, Booser, Daniel J., Ibrahim, Nuhad K., Conley, Anthony Paul, Bhosale, Priya, Rojas Hernandez, Cristhiam Mauricio, Tripathy, Debu, Naing, Aung, Meric-Bernstam, Funda

Volltext

First-in-human, phase I study of TT-00420, a multiple kinase inhibitor, as a single agent in advanced solid tumors von Piha-Paul, Sarina Anne, Xu, Binghe, Raghav, Kanwal Pratap Singh, Meric-Bernstam, Funda, Janku, Filip, Dumbrava, Ecaterina Elena, Fu, Siqing, Karp, Daniel D., Rodon Ahnert, Jordi, Conley, Anthony Paul, Mott, Frank, Ajani, Jaffer A., Hong, David S., Fan, Ying, Peng, Peng, Levin, Wendy J., Ngo, Brenda, Ru, Qinhua Cindy, Wu, Frank, Javle, Milind M.

Volltext

Targeting innate immunity with BXCL701 in combination with pembrolizumab in patients with advanced solid cancers: Phase 2 basket study von Karakuzu, Ozgur, Tsimberidou, Apostolia Maria, Holley, Veronica R., Adat, Abha, Patel, Sapna Pradyuman, Sood, Anil K., Conley, Anthony Paul, Urschel, Gabriele E, Healey, Diane I., O'Neill, Vincent, Janku, Filip

Volltext

PUMP HAVING DIAGNOSTIC SYSTEM von Conley, Paul G

Volltext bestellen

A phase 2 study of anti-PD-L1 antibody (atezolizumab) in grade 2 and 3 chondrosarcoma von Salkeni, Mohamad Adham, Conley, Anthony Paul, Chen, James Lin, Davis, Elizabeth J., Burgess, Melissa Amber, Abdul Razak, Albiruni Ryan, Moore, Nancy, Ferry-Galow, Katherine V., Fino, Kristin K., Fung, King Leung, Parchment, Ralph E., Foster, Jared C., Rosenberger, Christina, O'Sullivan Coyne, Geraldine Helen, Takebe, Naoko, Sharon, Elad, Doroshow, James H., Chen, Alice P.

Volltext

A phase II multi-arm study to test the efficacy of oleclumab and durvalumab in specific sarcoma subtypes von Somaiah, Neeta, Livingston, J Andrew Andrew, Ravi, Vinod, Lin, Heather Y., Amini, Behrang, Solis, Luisa Maren, Conley, Anthony Paul, Zarzour, Maria Alejandra, Ludwig, Joseph Aloysius, Ratan, Ravin, Wang, Wei-Lien, Araujo, Dejka M., Patel, Shreyaskumar, Roland, Christina Lynn, Lazar, Alexander J., Gorlick, Richard Greg, Parra, Edwin R., Haymaker, Cara L.

Volltext

Pump having diagnostic system von Conley, Paul G

Volltext bestellen

Precision oncology in sarcoma drug development: Impact of genomic matching on response, clinical benefit, and survival in sarcoma patients on phase 1 trials von Sen, Shiraj, Pestana, Roberto, Hess, Kenneth R., Hong, David S., Janku, Filip, Naing, Aung, Falchook, Gerald Steven, Conley, Anthony Paul, Patel, Shreyaskumar, Meric-Bernstam, Funda, Subbiah, Vivek

Volltext

Modulation of YAP/ TAZ by statins to improve survival in epithelioid hemangioendothelioma (EHE) von Subramaniam, Aparna, Zheng, Jing, Yalamanchili, Sudha, Conley, Anthony Paul, Ratan, Ravin, Somaiah, Neeta, Livingston, J Andrew, Zarzour, Maria Alejandra, Araujo, Dejka M., Benjamin, Robert S., Patel, Shreyaskumar, Ravi, Vinod

Volltext

Phase II study of atezolizumab in advanced alveolar soft part sarcoma (ASPS) von Naqash, Abdul Rafeh, O'Sullivan Coyne, Geraldine Helen, Moore, Nancy, Sharon, Elad, Takebe, Naoko, Fino, Kristin K., Ferry-Galow, Katherine V., Hu, James S., Van Tine, Brian Andrew, Burgess, Melissa Amber, Read, William L., Riedel, Richard F., George, Suzanne, Glod, John, Conley, Anthony Paul, Foster, Jared C., Fogli, Laura K., Parchment, Ralph E., Doroshow, James H., Chen, Alice P.

Volltext

A phase II multi-arm study of durvalumab and tremelimumab for advanced or metastatic sarcomas von Somaiah, Neeta, Conley, Anthony Paul, Lin, Heather Y., Amini, Behrang, Sabir, Sharjeel H, Araujo, Dejka M., Benjamin, Robert S., Livingston, J Andrew, Patel, Shreyaskumar, Ratan, Ravin, Ravi, Vinod, Zarzour, Maria Alejandra, Wang, Wei-Lien, Tate, Taylor, Roland, Christina Lynn, Daw, Najat C., Futreal, Andrew, Lazar, Alexander J., Wistuba, Ignacio Ivan, Hwu, Patrick

Volltext